Amber M. Yates, MD
Department or Service
Location
- Texas Medical Center
Specialty
Cancer
Phone: 832-822-4502
Contact Information
Research Area
- Hematology
- Sickle Cell Disease
Associate Director, Pediatric Hematology/Oncology Fellowship Program
Associate Professor, Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine
Education
| School | Education | Degree | Year |
|---|---|---|---|
| University of Tennessee College of Medicine | fellowship | Pediatric Hematology Oncology | 2010 |
| University of Tennessee College of Medicine | residency | Pediatrics | 2006 |
| Louisiana State University, Health Sciences Center, School of Medicine | medical school | Doctor of Medicine | 2003 |
| Northeast Louisiana University | bachelors | Bachelor of Science | 1999 |
About
Dr. Amber Yates is Associate Director of the Pediatric Hematology-Oncology Fellowship Program and a member of the Hematology Center.
Her primary clinical interest is in the care of children with sickle cell disease and other hemoglobin disorders. She is particularly interested in the role of hydroxyurea therapy in improving the lives of children with sickle cell disease, as well as the long term safety and efficacy of hydroxyurea. Her other clinical interests include: hemoglobinopathies and hemolytic anemia.
Dr. Amber Yates is also interested in assisting teenage patients with hematologic disorders so they can achieve a successful transition to adult care.
Board Certifications
American Board of Pediatrics
American Board of Pediatrics – Hematology/Oncology
Organization
| Organization Name | Role |
|---|---|
| American Academy of Pediatrics (AAP) | Member |
| American Academy of Pediatrics (AAP), Hematology-Oncology Executive Committee, Council on Communications and Media | Member |
| American Society of Hematology (ASH) | Member |
| American Society of Pediatric Hematology/Oncology (ASPHO) | Member |
| Texas Pediatric Society | Member |
Research Statement
Dr. Amber Yates' research interests are in sickle cell disease and hydroxyurea therapy.
Selected Publications
Awards
2018 Texas Children’s Cancer & Hematology Centers Faculty Recognition Award, Excellence in Teaching
2017 Norton Rose Fulbright Faculty Excellence Award, Teaching and Evaluation, Baylor College of Medicine
2017 American Society of Hematology Medical Educators Institute
Related Videos
-
Q&A: What is sickle cell disease? | Texas Children's Cancer and Hematology Centers -
Medically Speaking: Treatment Advances in Sickle Cell Disease, Amber M. Yates, MD